Meanwhile, at the fantasyland known as californiastemcellreport:
While the current president is reiterating his opposition to human embryonic stem cell research, investors are beginning to look to the future.
We have reported previously that the prospect of a favorable presidential change has eased some of the fears of stem cell investors. One further sign is the announcement today that UBS Investment Research upgraded Geron Corp. of Menlo Park, Ca., from neutral to a buy recommendation on its stock.
of the state of the union speech the report noted:
The California stem cell agency is accusing President Bush of distorting facts and performing a disservice to millions of Americans who suffer from chronic diseases and injuries.
The agency said Bush intends to "further limit" research into human embryonic stem cells.
The CIRM statement is contained in a press release on its web site that concerned Bush's speech Tuesday night. Interestingly, the CIRM statement is not attributed to either Bob Klein, chairman of the agency, or its new president, Australian stem cell researcher Alan Trounson. In the past, statements such as this have been linked to either the president or chairman.
But carefully note, the californiastemcellreport itself is not accusing Bush of distorting facts, merely quoting someone [hmmm, some entity?] else who is.
Trivia: Rand McNally developed a numbering system for US highways in 1917.